Figure 1From: Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: An observational studyTime to progression (months) for 1st, 2nd, 3rd, and 4th line trastuzumab based combination therapy.Back to article page